SMTL ID : 6ny4.1

Crystal structure of JAK3 kinase domain in complex with a pyrrolopyridazine carboxamide inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.33 Å

Oligo State

monomer

Ligands

1 x Z3A: 4-{[(2R,3R)-1,3-dihydroxybutan-2-yl]amino}-6-phenylpyrrolo[1,2-b]pyridazine-3-carboxamide(Non-covalent)

Z3A.1: 16 residues within 4Å: Chain A: L.21, G.22, V.29, A.46, V.77, M.95, E.96, Y.97, L.98, P.99, G.101, R.146, N.147, L.149, A.159, D.160 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.21, A:L.21, A:A.46, A:L.149, A:A.159 Hydrogen bonds: A:G.22, A:E.96, A:L.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Spergel, S.H. et al., Discovery of a JAK1/3 Inhibitor and Use of a Prodrug To Demonstrate Efficacy in a Model of Rheumatoid Arthritis. Acs Med.Chem.Lett. (2019)

Release Date

2019-05-22

Peptides

Tyrosine-protein kinase JAK3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK3

Related Entries With Identical Sequence